NC (n = 28) | cMS (n = 35) | aMS (n = 57) | |
---|---|---|---|
Age (years) | 13.3 ± 2.8 (10–16) | 13.2 ± 2.0 (8–16) | 37.4 ± 7.2 (18–55)a,b |
Age at onset (years) | n.a. | 12.5 ± 1.8 (7–15) | 36.9 ± 6.9 (18–54)b |
Patients with BOIgG | n.a | 30 (85.7%) | 51 (89.5%) |
EDSS-baseline | n.a. | 1.4 ± 0.8 (0–3.0) | 3.2 ± 1.5 (1.0–7.0)b |
T2WMLV (cm3) | n.a. | 4.0 ± 5.9 (0.2–27.5) | 7.4 ± 9.4 (0.3–67.6)b |
Patients with CEL | n.a. | 7 (20.0%) | 12 (21.1%) |
Number of CEL | n.a. | 1.3 ± 0.4 (1–4) | 1.1 ± 0.3 (1–3) |
GMf-baseline % | 53.9 ± 2.0(49.4–57.6) | 53.0 ± 2.8(49.9–56.2) | 49.9 ± 3.3(47.3–53.0)a,b |
Patients with CLs | n.a. | 12 (34.3%) | 35 (61.4%)b |
CL number | n.a | 2.1 ± 1.7 (1–12) | 3.8 ± 2.6 (1–20)b |
CL volume (mm3) | n.a | 240 ± 89 (0–745) | 451 ± 125 (0–1250)b |